European Equity pre-Market Summary - 29th September 2026: European bourses set for a slightly firmer open; Hapag lifts outlook, with Lindt issues a profit warning
Every headline is on the live feed 20 minutes before this site.
Additional European Equity News - 29th September 2026
An explosion was reported in the Strait of Hormuz, which is said to be a commercial ship which passed through the southern route of the Strait, Fars reports citing Ambrey
European Equity pre-Market Summary - 29th September 2026: European bourses set for a slightly firmer open; Hapag lifts outlook, with Lindt issues a profit warning
Houthis reportedly attacked oil facilities in Yanbu on the Red Sea with a large number of ballistic missiles and drones; satellites showed several giant oil storage tanks at the Al-Mu'ajiz terminal in southern Saudi Arabia ablaze, Al Akhbar reports
Newsquawk Daily European Equity Opening News - 29th September 2026
On the Newsquawk feed at , 20 minutes before this page.
Stories
- AstraZeneca (AZN LN): Co. is to invest USD 2bln in Summit Therapeutics (SMMT) and collaborate on cancer drugs, according to WSJ.
- Airbus (AIR FP): Co. faces slower-than-expected deliveries in September after recently discovered A321neo fuselage glitch, Reuters reports citing sources.
- Rexel (RXL FP): Co. launches a c. EUR 500mln capital increase, without shareholders’ preferential subscription right, to partially fund the acquisition of GCG.
Trading Updates
- Hapag Lloyd (HLA GY): Co. raises outlook for FY26, citing strong market demand and the ongoing positive development of spot freight rates.
- Lindt & Spruengli (LISN SW), -5.7%: H1 2026 (CHF): Sales 2.33bln (exp. 2.36bln). Cuts FY26 Organic Sales Growth to 0-2% (prev. guided 4-6%).
Broker Moves
- Rentokil (RTO LN), -1.6%: downgraded to Equal Weight from Overweight at Morgan Stanley
- Fresenius Medical Care (FME GY): assumed with Hold at Berenberg
- Eurofins Scientific (ERF FP), -1.5%: downgraded to Market Perform from Outperform at Bernstein
The numbers after the Co. & ticker are the pre-market indication via Tradegate
Context
A pre-market wrap of this kind is a liquidity and positioning note rather than a signal event; its value lies in which items carry follow-through into the cash session and which fade at the open. The pattern that has recurred in comparable sessions is that idiosyncratic corporate news drives single-stock dispersion while the index-level indication, here only slightly firmer, tends to be hostage to the US session and any macro prints later in the day. The Lindt cut is the cleanest read-through: a guidance reset of that magnitude in a defensive staple has historically prompted peer scrutiny across European consumer names on pricing power and volume elasticity, and the size of the pre-market markdown relative to the downgrade-driven moves in Rentokil and Eurofins reflects the difference between new fundamental information and a rerating of existing views. Hapag's upgrade, tied to spot freight rates, is the cyclical counterpoint and typically pulls the container peer set with it, since freight-rate momentum is a shared input rather than company-specific. The Airbus delivery slippage and the Rexel discounted raise are supply-chain and dilution stories respectively, the former watched for read-across to the aerospace supplier chain, the latter for the discount and take-up as the tell on appetite for acquisition-funding paper. Follow-ons are the cash-open confirmation of the Tradegate indications, any broker response to the Lindt reset, and whether the AstraZeneca-Summit collaboration is corroborated beyond the initial report.
Related headlines
- European Equity pre-Market Summary – 9th October 2026: European bourses set for a firmer open8 hours ago
- Week in Focus 12-16th October 2026: US CPI, US Retail Sales, Start of Q3 Earnings, China CPI, UK jobs, RBA Minutes and Aussie jobs1 hour ago
- Newsquawk European Market Wrap - 9th October 202630 min ago
- EUROPEAN OPEN: AAPL cuts Oct iPhone 18 Pro component orders; AIR FP Sept deliveries flat Y/Y; SPCX agrees USD 8bln spectrum acquisition; ROP SW wins FDA approval for colon cancer drug; RBC expects MBG GY to issue a profit warning7 hours ago
- [MARKET ANALYSIS] DXY under mild pressure; G10s broadly firmer, with outperformance in the Antipodeans5 hours ago
- US BROKER MOVES: CBOE upgraded at Morgan Stanley; DD downgraded at JPM2 hours ago
- [MARKET ANALYSIS] USTs a touch lower, whilst Bunds and Gilts benefit from easing energy prices4 hours ago
- [MARKET ANALYSIS] European bourses supported by lower energy prices as earnings season gets underway next week5 hours ago
- European Movers: Deutsche Telekom (DTE GY) -5.9%, Roche (ROP SW) +1%, Bureau Veritas (BVI FP) +3%, Salzgitter (SZG GY) +7%, 7 hours ago
- Russian Kremlin says a call between President Putin and US President Trump will take place soon, Ifx1 hour ago
- Chinese Foreign Ministry says reports that Chinese and US officials discussed reciprocal visits to nuclear facilities are inconsistent with the facts7 hours ago
- US Treasury Secretary Bessent may skip the APEC finance ministers’ meeting in Hong Kong to focus on talks with Chinese Vice-Premier He Lifeng in Shenzhen ahead of President Trump’s November visit, SCMP sources reports7 hours ago
- [MARKET ANALYSIS] Crude pulls back on Trump's Iran assurances, although supply concerns limit downside6 hours ago
- US EQUITY OPEN: Stocks open higher with Nasdaq leading gains27 min ago
- AstraZeneca (AZN LN) biopharma head says that they are on track to hit 2030 revenue target3 hours ago
- China's Commerce Ministry says minister had pragmatic and productive talks with EU trade chief; two sides agreed to hold third regular meeting of mechanism in March 20273 hours ago
- Samsung Electronics (005930 SK) has reportedly secured long term trade agreements covering 75-80% of its memory supply volume for next-year, Hankyung reports 7 hours ago
- [MARKET UPDATE] Energy futures rise in recent trade, weighing on fixed income markets and slightly on sentiment; recent news flow light8 hours ago
- Johnson & Johnson (JNJ) says 2-year ICOTYDE data in moderate-to-severe plaque psoriasis showed sustained efficacy through week 1123 hours ago
- Eli Lilly (LLY) announces new exploratory data from the TOGETHER-PsO Phase 3b clinical trial evaluating the concomitant use of Taltz and Zepbound in adults with Psoriasis and Obesity3 hours ago
The feed had this first.
Use the Platform